IMPEL NEUROPHARMA INC (IMPL): Price and Financial Metrics

IMPEL NEUROPHARMA INC (IMPL): $0.04

0.02 (-27.27%)

POWR Rating

Component Grades

Momentum

D

Stability

F

Sentiment

Quality

D

Add IMPL to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#221 of 359

in industry

IMPL Price/Volume Stats

Current price $0.04 52-week high $4.20
Prev. close $0.06 52-week low $0.02
Day low $0.02 Volume 720,000
Day high $0.05 Avg. volume 682,655
50-day MA $0.34 Dividend yield N/A
200-day MA $0.97 Market Cap 956.00K

IMPL Stock Price Chart Interactive Chart >


IMPEL NEUROPHARMA INC (IMPL) Company Bio


Impel NeuroPharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of therapies for patients suffering from central nervous system disease in the United States. Its lead product candidate is TRUDHESA, an upper nasal formulation of dihydroergotamine for the acute treatment of migraine. The company is also developing INP105, an upper nasal formulation of olanzapine for the acute treatment of agitation and aggression in autism spectrum disorder; and INP107, an upper nasal formulation of carbidopa/levodopa for the treatment of OFF episodes in Parkinson's disease. Impel NeuroPharma, Inc. was incorporated in 2008 and is headquartered in Seattle, Washington.


IMPL Latest News Stream


Event/Time News Detail
Loading, please wait...

IMPL Latest Social Stream


Loading social stream, please wait...

View Full IMPL Social Stream

IMPL Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year -94.87%
3-year -99.58%
5-year N/A
YTD N/A
2023 0.00%
2022 -56.55%
2021 N/A
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!